Elizabeth M. Anderson is Director at Revolution Medicines, Inc. (RVMD). They have made 4 open-market trades across 2 companies since 2020, most recently 2026-09-22.
CIK 0001758247
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INSM | 62,034 | $6.0M |
| BMRN | 41,940 | $2.3M |
| RVMD | 4,333 | $772K |
| Total | $9.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-09-22 | 2026-09-24 | $193.04 | $2.0M | -0.3% | — | — |
| INSM | SELL | 2025-11-24 | 2025-11-26 | $204.58 | $2.0M | -5.8% | -13.7% | -23.1% |
| INSM | SELL | 2025-11-14 | 2025-11-18 | $195.87 | $2.0M | +5.1% | -17.2% | -25.1% |
| RVMD | SELL | 2020-10-13 | 2020-10-15 | $45.00 | $225K | -24.7% | -8.4% | -12.4% |
| RVMD | SELL | 2020-10-06 | 2020-10-08 | $40.00 | $200K | +5.8% | -14.5% | -1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.